FDA Clearance Tracker · P160001-S018
Obalon Balloon Kit
Last checked: Nov 20, 2026Latest source record: Aug 1, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Aug 1, 2018
Approved
Time to decision
77 days
Received May 16, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160001-S018
- Device name
- Obalon Balloon Kit
- Applicant
- Medtimo, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- May 16, 2018
- Decided
- Aug 1, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P160001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Obalon Balloon System. The device is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 to 40 kg/m2) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed 6 months after the first balloon is placed.
Source documents
Other decisions for Medtimo, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160001 · Decided Sep 8, 2016 · 245 days after receipt
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.